Glaucoma

Glaucoma is a group of diseases that can damage the eye's optic nerve and result in vision loss and blindness. Glaucoma occurs when the normal fluid pressure inside the eyes slowly rises. However, with early treatment, a person can often protect the eyes against serious vision loss. It is the damage to the optic nerve that steals sight from people with glaucoma. Anyone can develop glaucoma, but it is five times more likely to occur in African Americans than in Caucasians.

Company Product Phase  
Allergan Inc Ganfort PA Glaucoma
Allergan Inc Lumigan X PA Glaucoma
Allergan Inc Alphagan P M Glaucoma
Allergan Inc Betagan M Glaucoma
Santen Inc Betimol M Glaucoma
Allergan Inc Combigan M Glaucoma
Valeant Pharmaceuticals International Glaucostat M Glaucoma
Valeant Pharmaceuticals International Glauteolol M Glaucoma
ISTA Pharmaceuticals Inc Istalol M Glaucoma
Allergan Inc Lumigan M Glaucoma
Solvay Luvox M Glaucoma
Allergan Inc Propine M Glaucoma
Allergan Inc AGN210669 II Glaucoma
Allergan Inc Brimonidine II Glaucoma
Chakshu Research C-KAD II Glaucoma
Allergan Inc IOP Lowering II Glaucoma
Allergan Inc PG analog II Glaucoma

Macular Degeneration

Most vision loss in people over the age of 55 is due to macular degeneration, a condition that affects 10 million Americans. Because the condition usually develops with age, it is generally referred to as Age-Related Macular Degeneration (ARMD). There are two types of ARMD: dry and wet. Dry ARMD occurs when the cells of the macula simply begin to break down. This process is usually slow and results in a blurred spot in the center of the field of vision. Wet ARMD is rarer than the dry form, but the results are much worse. It occurs when blood vessels behind the retina begin leaking blood and fluid behind the macula. As fluids fill the macula, one’s vision changes shape, causing straight lines to appear curved and the picture to blur.

Company Product Phase  
Miravant Medical Technologies Photrex (rostaporfin) PA Macular Degeneration
Genentech Inc Lucentis M Macular Degeneration
Gilead Sciences Inc Macugen M Macular Degeneration
Genentech, Inc. Lucentis III Macular Degeneration
CoMentis Inc ATG3 II Macular Degeneration
Allergan Inc Brimonidine tartrate II Macular Degeneration
Intradigm Corporation Cand5 II Macular Degeneration
Allergan Inc Dexamethasone with Anti-VEGF II Macular Degeneration
Genentech, Inc. Lucentis with Bromfenac II Macular Degeneration
Genentech Inc Lucentis with Visudyne II Macular Degeneration
Amgen Inc NT501 II Macular Degeneration
Quark Pharmaceuticals Inc RTP801i II Macular Degeneration
TargeGen Inc TG 100801 II Macular Degeneration
OXiGENE INC Zybrestat II Macular Degeneration